Umbilical Artery Access for PDA Stenting: Feasibility in Select Anatomy
Pediatric Cardiology · 2026-08 · 47 (6) · 2481-2489
DOI: 10.1007/s00246-026-04215-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, online erschienen am 26.03.2026. Verfasst von Thomas Roberts und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of California, San Diego, La Jolla, San Diego, CA, USA. tom.roberts.22@ucl.ac.uk. Hauptthemen laut MEDLINE: Ductus Arteriosus, Patent, Stents, Umbilical Arteries, Cardiac Catheterization. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Patent ductus arteriosus (PDA) stenting is a less invasive alternative to surgical shunts in ductal-dependent congenital heart disease. Umbilical artery access for PDA stenting offers femoral-like retrograde advantages while avoiding associated risks, however is underreported in this context. This study evaluates umbilical artery access feasibility and outcomes for PDA stenting. A case series included seven neonates undergoing PDA stenting via umbilical artery access between 01/17/2020 and 10/30/2024 at Rady Children’s Hospital, San Diego. Patient demographics, PDA morphology, and procedural details were collected. Existing umbilical arterial lines were rewired and exchanged for a 4 F Flexor sheath (Cook Medical Bloomington, Indiana, USA), advanced through the iliac artery to the descending aorta. A coaxial system was used to cross the PDA and deploy coronary stents with a wire-locking technique for controlled positioning. Post-procedure, patients received dual antiplatelet therapy with the umbilical catheter remaining in situ until stability. This study (71% female) had a median gestational age of 38 weeks and a median birth weight of 2.97 kg. The median age at catheterization was 8 days (range: 3–10). PDA morphology originated from the descending aorta ( n = 4, 57.1%) and the brachiocephalic artery ( n = 3, 42.9%). The median procedure time was 126 min (range: 42–161 min), with a median fluoroscopy time of 24.7 min (11.4–58.6). No intra- or post-procedural complications occurred. Median stent diameter was 3.5 mm; 85.7% required one stent. Scheduled reinterventions, as part of staged palliation, were performed in a subset of patients. Umbilical artery access for PDA stenting is a safe and effective alternative in select cases, with no acute complications in our study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of California, San Diego, La Jolla, San Diego, CA, USA. tom.roberts.22@ucl.ac.uk.
- Department of Pediatrics, University of California, San Diego, La Jolla, San Diego, CA, USA.
- Division of Cardiology, Rady Children's Hospital, San Diego, CA, USA.
- Helen and Will Webster Foundation 3D Innovations Lab, Rady Children's Hospital, San Diego, CA, USA.
- Department of Neurological Surgery, UC San Diego Health, La Jolla, CA, USA.
- Department of Neonatology Surgery, UC San Diego Health, La Jolla, CA, USA.
Zitieren
APA
Roberts, T., Hesari, M., Peterson, D., Gomez-Arostegui, J., Fulk, C., Ryan, J., Suttner, D., Nigro, J., & El-Said, H. (2026). Umbilical Artery Access for PDA Stenting: Feasibility in Select Anatomy. Pediatric Cardiology, 47(6), 2481-2489. https://doi.org/10.1007/s00246-026-04215-1
Vancouver
Roberts T, Hesari M, Peterson D, Gomez-Arostegui J, Fulk C, Ryan J, et al. Umbilical Artery Access for PDA Stenting: Feasibility in Select Anatomy. Pediatric Cardiology. 2026;47(6):2481-2489. doi:10.1007/s00246-026-04215-1
BibTeX
@article{Roberts2026,
author = {Roberts, Thomas and Hesari, Marjan and Peterson, Danica and Gomez-Arostegui, Juliana and Fulk, Clinton and Ryan, Justin and Suttner, Denise and Nigro, John and El-Said, Howaida},
title = {Umbilical Artery Access for PDA Stenting: Feasibility in Select Anatomy},
journal = {Pediatric Cardiology},
year = {2026},
volume = {47},
number = {6},
pages = {2481--2489},
doi = {10.1007/s00246-026-04215-1}
}
EUVIMED